Physician profile
Douglas Eli Cunningham
NPI 1699761874
$1,385.72
in general payments reported to CMS, 2019-2025
6 companies · $78.65 in 2025
The $78.65 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $149 · 2021: $116 · 2022: $95.49 · 2023: $709 · 2024: $238 · 2025: $78.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $920.95 | 2020-2024 | Apretude, Cabenuva |
| Gilead Sciences, INC. | $321.10 | 2023-2025 | Biktarvy |
| Organogenesis INC. | $63.11 | 2023 | Puraply |
| Smith+Nephew, INC. | $48.24 | 2022-2023 | Regranex, Collagenase Santyl |
| Sumitomo Pharma America, INC. | $19.03 | 2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.29 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.